Salim Syed
Stock Analyst at Mizuho
(0.63)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NKTX Nkarta | Maintains: Outperform | 16 14 | 1.66 | 743.37% | 8 | Jun 10, 2025 | |
CYTK Cytokinetics | Maintains: Outperform | 103 84 | 33.05 | 154.16% | 7 | May 29, 2025 | |
BIIB Biogen | Maintains: Outperform | 207 169 | 125.57 | 34.59% | 16 | May 7, 2025 | |
AMGN Amgen | Maintains: Neutral | 235 280 | 279.22 | 0.28% | 8 | May 7, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 100 117 | 110.9 | 5.5% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 22 | 6.5 | 238.46% | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 113 163 | 32.52 | 401.23% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 18 | 7.74 | 132.56% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 20.06 | 69.49% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 82 99 | 48.66 | 103.45% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 53 | 43.23 | 22.6% | 7 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | n/a | n/a | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 0.73 | 2776.71% | 5 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 168 36 | 18.12 | 98.68% | 1 | Nov 16, 2022 |